Compare UTHR & DG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UTHR | DG |
|---|---|---|
| Founded | 1996 | 1939 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Department/Specialty Retail Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.3B | 22.4B |
| IPO Year | 1999 | N/A |
| Metric | UTHR | DG |
|---|---|---|
| Price | $504.73 | $136.38 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 23 |
| Target Price | ★ $495.08 | $129.43 |
| AVG Volume (30 Days) | 428.3K | ★ 4.8M |
| Earning Date | 10-29-2025 | 12-04-2025 |
| Dividend Yield | N/A | ★ 1.72% |
| EPS Growth | ★ 16.08 | N/A |
| EPS | ★ 26.38 | 5.79 |
| Revenue | $3,128,400,000.00 | ★ $42,117,664,000.00 |
| Revenue This Year | $13.64 | $7.83 |
| Revenue Next Year | $5.78 | $4.16 |
| P/E Ratio | ★ $19.37 | $23.65 |
| Revenue Growth | ★ 13.50 | 4.86 |
| 52 Week Low | $266.98 | $66.43 |
| 52 Week High | $513.93 | $137.60 |
| Indicator | UTHR | DG |
|---|---|---|
| Relative Strength Index (RSI) | 67.62 | 76.28 |
| Support Level | $483.52 | $123.86 |
| Resistance Level | $513.93 | $135.08 |
| Average True Range (ATR) | 11.03 | 4.83 |
| MACD | 1.04 | 1.52 |
| Stochastic Oscillator | 80.46 | 94.50 |
United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing a pipeline of projects that includes new indications and delivery devices for existing products and new products to treat PAH and other conditions.
With more than 20,000 locations, Dollar General's banner is nearly ubiquitous across the rural United States. Dollar General serves as a convenient shopping destination for fill-in store trips, with its value proposition most relevant to consumers in small communities with a dearth of shopping options. The retailer operates a frugal store of about 7,500 square feet and primarily offers an assortment of branded and private-label consumable items (80% of net sales) such as paper and cleaning products, packaged food, and health and beauty items at low prices. Dollar General also offers a limited assortment of seasonal merchandise, home products, and apparel. The firm sells most items at a price point of $10 or less.